Becton, Dickinson and Company's latest marketcap:
As of 06/26/2025, Becton, Dickinson and Company's market capitalization has reached $48.71 B. According to our data, Becton, Dickinson and Company is the 446th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 48.71 B |
| Revenue (ttm) | 20.87 B |
| Net Income (ttm) | 1.5 B |
| Shares Out | 286.61 M |
| EPS (ttm) | 5.16 |
| Forward PE | 12.00 |
| Ex-Dividend Date | 06/09/2025 |
| Earnings Date | 08/07/2025 |
Becton, Dickinson and Company's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | $48.71 B | -25.84% | 446 |
| 12/31/2024 | $65.59 B | -7.37% | 289 |
| 12/29/2023 | $70.81 B | -1.74% | 231 |
| 12/30/2022 | $72.06 B | 0.89% | 189 |
| 12/31/2021 | $71.43 B | -1.58% | 245 |
| 12/31/2020 | $72.57 B | -1.34% | 199 |
| 12/31/2019 | $73.56 B | 21.69% | 155 |
| 12/31/2018 | $60.44 B | 23.86% | 146 |
| 12/29/2017 | $48.8 B | 38.84% | 235 |
| 12/30/2016 | $35.15 B | 8.24% | 277 |
Company Profile
About Becton, Dickinson and Company
Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells a wide range of medical supplies, devices, laboratory equipment, and diagnostic products. Serving healthcare institutions, physicians, researchers, clinical laboratories, and the pharmaceutical industry, BD operates through three key segments:
BD Medical Segment
This segment focuses on medication management and patient safety solutions, including:
- Vascular Access: Peripheral IV catheters, central lines, dialysis catheters, and vascular care products.
- Medication Delivery: Needle-free IV connectors, closed-system drug transfer devices, and infusion therapy systems.
- Pharmacy Automation: Automated dispensing, inventory tracking, and compounding workflow systems.
- Prefillable Solutions: Drug delivery systems and hypodermic syringes.
BD Life Sciences Segment
This segment provides diagnostic and research tools, such as:
- Specimen Collection: Blood collection products and liquid-based cytology systems.
- Microbiology Solutions: Automated culturing, molecular testing, and rapid diagnostic assays.
- Flow Cytometry: Cell sorters, analyzers, and reagents for clinical and research applications.
BD Interventional Segment
This segment offers surgical and interventional products, including:
- Surgical Repair: Hernia and soft tissue grafts, biosurgery products.
- Infection Prevention: Solutions to reduce surgical infections.
- Urology & Critical Care: Specialized medical devices for patient care.
Founded in 1897, BD is headquartered in Franklin Lakes, New Jersey, and continues to innovate in medical technology worldwide.
Frequently Asked Questions
-
What is Becton, Dickinson and Company's (BDX) current market cap?As of 06/26/2025, Becton, Dickinson and Company (including the parent company, if applicable) has an estimated market capitalization of $48.71 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Becton, Dickinson and Company (BDX) rank globally by market cap?Becton, Dickinson and Company global market capitalization ranking is approximately 446 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.